SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)

Market Cap	3.03B
Revenue (ttm)	975.68M
Net Income (ttm)	146.87M
Shares Out	n/a
EPS (ttm)	0.97
PE Ratio	20.61
Forward PE	18.28
Dividend	0.16 (0.80%)
Ex-Dividend Date	Feb 5, 2025

Volume	21,404
Average Volume	55,251
Open	20.20
Previous Close	20.30
Day's Range	20.10 - 20.35
52-Week Range	18.50 - 32.74
Beta	n/a
RSI	38.76
Earnings Date	Dec 11, 2025

About FRA:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. It offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1884
• Employees: 4,690
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1SXP

Financial Performance

In 2024, FRA:1SXP's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.